vs
Side-by-side financial comparison of Dexcom (DXCM) and Hudbay Minerals Inc. (HBM). Click either name above to swap in a different company.
Hudbay Minerals Inc. is the larger business by last-quarter revenue ($2.0B vs $1.3B, roughly 1.6× Dexcom). Dexcom runs the higher net margin — 21.2% vs 3.4%, a 17.9% gap on every dollar of revenue.
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Hudbay Minerals Inc. is a Canadian mining company that produces copper, gold, silver, zinc, and molybdenum. In 2024, the company produced 137,943 tonnes of copper, 332,240 ounces of gold, 3,983,851 ounces of silver, 33,339 tonnes of zinc, and 1,323 tonnes of molybdenum. In 2024, copper sales represented 57% of revenue, gold sales represented 33% of revenue, and zinc sales represented 4% of revenue.
DXCM vs HBM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $2.0B |
| Net Profit | $267.3M | $67.8M |
| Gross Margin | 62.9% | 27.4% |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | 3.4% |
| Revenue YoY | 21.6% | — |
| Net Profit YoY | 153.6% | — |
| EPS (diluted) | $0.67 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $2.0B | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.0B | $525.0M | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $994.2M | — | ||
| Q2 24 | $1.0B | — |
| Q1 26 | $267.3M | $67.8M | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | — | ||
| Q2 25 | $179.8M | — | ||
| Q1 25 | $105.4M | $18.5M | ||
| Q4 24 | $151.7M | — | ||
| Q3 24 | $134.6M | — | ||
| Q2 24 | $143.5M | — |
| Q1 26 | 62.9% | 27.4% | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | 29.0% | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 12.9% | — | ||
| Q4 24 | 17.0% | — | ||
| Q3 24 | 15.3% | — | ||
| Q2 24 | 15.7% | — |
| Q1 26 | 21.2% | 3.4% | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | — | ||
| Q2 25 | 15.5% | — | ||
| Q1 25 | 10.2% | 3.5% | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 14.3% | — |
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | — | ||
| Q2 25 | $0.45 | — | ||
| Q1 25 | $0.27 | — | ||
| Q4 24 | $0.37 | — | ||
| Q3 24 | $0.34 | — | ||
| Q2 24 | $0.35 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | — |
| Total Assets | $6.3B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | — | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $904.9M | — | ||
| Q4 24 | $606.1M | — | ||
| Q3 24 | $621.2M | — | ||
| Q2 24 | $939.2M | — |
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.7B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.3B | — | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | — | ||
| Q2 24 | $2.4B | — |
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | — | ||
| Q3 25 | $7.5B | — | ||
| Q2 25 | $7.3B | — | ||
| Q1 25 | $6.8B | — | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.8B | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
